a history of the most notorious zoonotic diseases · & re-emerging infectious diseases the...
TRANSCRIPT
The animal health industry is actively working with governments and regulators around the world to try
to overcome the many challenges still existing to ensure that veterinary medicines can be delivered
quickly and effectively when needed
Salmonella costs the USA
as much as $3bn annually
World Zoonosis Day6TH July 2015
A history of the mostnotorious zoonotic diseases
i To find out more on how protecting our animals will help protect our world visit www.HealthforAnimals.org/who-we-are/zoonoses-outbreaks or join the debate on Twitter @HealthforAnimals
Global examples of emerging & re-emerging infectious diseases
The economic impact of recent zoonotic disease outbreaks
Up to 75% of all human diseases are zoonotic
in origin, meaning they are naturally
transmitted between animals and humans
Currently there are over 200 identified
zoonotic diseases that represent a clear threat
to our health and the welfare of animals
Up to 20% of global animal production is
lost to disease
The impact of zoonotic epidemics from 1995
to 2008, many of them preventable, exceeded
$120 billion globally
Some zoonotic diseases such as rabies
can be eradicated
Preventive veterinary medicines & the widespread
use & development of vaccines play an increasingly
important role globally in effective disease control
200+75% $$120Bn20%
A historical timeline of some of the most notorious zoonotic diseases demonstrates a highly probable increase in incidences over the years. This is most likely due to a growing population, increased globalisation, travel, international trade, pet ownership, socio-economic factors and climate change.
Black Death (plague) Europe 1347
Yellow fever South America16th century
Salmonella USA 1885
EbolaAfrica1976
Lyme diseaseUSA1975
H5N1 (avian influenza) China1997
Nipah virusMalaysia1999
Rabies Italy1546
Brucellosis Malta1850s
Cryptosporidiosis USA1907
Influenza pandemicGlobal1918
HIV / AIDSUSA1983
BSEEuropeMid 1980s
H1N1 Swine influenzaUSA 2009
SARS (Severe acute respiratory syndrome) China 2003
MERS-CoV Middle East Respiratory Syndrome coronavirus2012
E-coli Germany 1885
1200 AD
150
125
50
25
0
1990 1995 2000 2005 2010 2015
1300
1400
1500
1600
1700
1800
1900
2000
RISK
Newly emerging Re-emerging/resurging Deliberately emerging
Estim
ated
cost
($BN
)
Lassa fever
Hepatitis C
Lyme disease
Cyclosporiasis
vCJD
Cryptosporidiosis
HIV
Enterovirus 71
Hendra virus
Nipah virus
H5N1influenza
E. coli0157:H7
E. coli 0157:H7
Whitewater arroyo virus
Anthraxbioterrorism
Hantavirus pulmonary syndrome
SARS
Dengue Yellow fever Cholera Marburg hemorrhagic fever
Ebola hemorrhagic fever
Plague
Human monkeypox
Human monkeypox
West Nile virus
Rift Valley fever
Diptheria
Vancomycin-resistant
Staphylococcus aureus
Vancomycin-resistantStaphylococcus aureus
Drug-resistant malariaMultidrug-resistant tuberculosis
Typhoid fever
Credit: Bio Economic Research Associates, LLC ©., 12 August 2008. SARS and the New Economics of Biosecurity, 2003
EbolaAfrica
2014-15$1.6bnLyme disease
USA2002
$200m
H5N1 Avian influenza
Worldwide1997$30bn
Nipah virusAsia1999
$350-400m
BSE UK1995 $5bn
BSEUSA & Canada
2003-04$6.5bn
SARS China, Hong Kong, Singapore, Canada
2003 $30-50bn
E-coli 0157:H7USA2010
$489-993mn
H1N1 Swine influenza
Worldwide2009
$45-55bn
Rabies Worldwide
2013$124bn